Innoviva, Inc. - 12 Mar 2025 SCHEDULE 13D/A Report for Armata Pharmaceuticals, Inc. Common Stock, $0.01 par value (ARMP)

Filing Manager
Innoviva, Inc.
Reporting Manager
Innoviva, Inc.
Security
Armata Pharmaceuticals, Inc. Common Stock, $0.01 par value
Symbol
ARMP
Shares outstanding
75,326,595 shares
Disclosed Ownership
64,178,259 shares
Ownership
85%
Form type
SCHEDULE 13D/A
Filing time
12 Mar 2025, 17:49:26 UTC
Date of event
12 Mar 2025
Next filing
12 Aug 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Innoviva, Inc. 85% 64,178,259 17,421,600 46,756,659 /s/ Pavel Raifeld Pavel Raifeld, Chief Executive Officer 0001080014
Innoviva Strategic Opportunities LLC 62% 46,756,659 0 46,756,659 /s/ Pavel Raifeld Pavel Raifeld, Chief Executive Officer